Apolipoprotein E-deficient Mice Have Impaired Innate Immune Responses to Listeria Monocytogenes in Vivo
Overview
Authors
Affiliations
Apolipoprotein E (apoE) influences both innate and acquired immunity in cultured cells. To determine whether apoE affects the immune system in vivo, Listeria monocytogenes (LM) was administered intraperitoneally (10(4) c.f.u.) to congenic C57BL/6 apoE-/- and +/+ mice (n = 12 in each group). Survival was assessed daily for 5 days. Deficiency of apoE significantly increased death by day 5 (P = 0.03). The majority of deaths occurred at day 4. Extent of infection after LM administration was assessed at day 3 by determining colony counts in hepatic and splenic extracts. ApoE+/+ mice had very low colony counts in both spleen and liver [mean +/- SE: 2.0 +/- 0.5 and 0.7 +/- 0.2 (x 10(4)), respectively, n = 8 in each group]; while apoE-/- mice had significantly increased counts in both spleen and liver [64 +/- 51 and 98 +/- 93 (x 10(4)), P = 0.05 and 0.03]. Serum concentrations of TNF-alpha were significantly increased in apoE-/- mice at day 3 compared to apoE+/+ mice (127 +/- 43 pg/ml versus 20 +/- 17, P = 0.003). LM induced more hepatic damage in apoE-/- mice compared to apoE+/+ mice as judged by increased serum concentrations of alanine aminotransferase at day 1 (apoE-/- 301 +/- 45 U/ml, apoE+/+ 101 +/- 9 U/ml, P = 0.01). The increased proliferation and mortality from LM in apoE-/- mice occurred prior to the initiation of acquired immune responses. Therefore, apoE-deficient mice have an impaired innate response to infection by LM.
Liu D, Mai D, Jahn A, Murray T, Aitchison J, Gern B bioRxiv. 2024; .
PMID: 39605723 PMC: 11601580. DOI: 10.1101/2024.10.04.616580.
Henlon Y, Panir K, McIntyre I, Hogg C, Dhami P, Cuff A Proc Natl Acad Sci U S A. 2024; 121(38):e2405474121.
PMID: 39255000 PMC: 11420174. DOI: 10.1073/pnas.2405474121.
Apolipoprotein E genotype affects innate susceptibility to infection in aged male mice.
Cho J, Alexander K, Ferrell J, Johnson L, Estus S, DOrazio S Infect Immun. 2023; 91(9):e0025123.
PMID: 37594272 PMC: 10501219. DOI: 10.1128/iai.00251-23.
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury.
Laskowitz D, Van Wyck D Neurotherapeutics. 2023; 20(6):1496-1507.
PMID: 37592168 PMC: 10684461. DOI: 10.1007/s13311-023-01413-0.
Huebbe P, Bilke S, Rueter J, Schloesser A, Campbel G, Gluer C Aging Dis. 2023; 15(1):259-281.
PMID: 37450924 PMC: 10796091. DOI: 10.14336/AD.2023.0530.